Related Experiment Video
Updated: Mar 28, 2026

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy
Magdalena M Schimke1, Sabrina Marozin1, Günter Lepperdinger1
1Department of Cell Biology and Physiology, Stem Cell Research, Aging and Regeneration, University Salzburg Salzburg, Austria.
Abstract:
Multipotential mesenchymal stromal cells (MSC) are present as a rare subpopulation within any type of stroma in the body of higher animals. Prominently, MSC have been recognized to reside in perivascular locations, supposedly maintaining blood vessel integrity. During tissue damage and injury, MSC/pericytes become activated, evade from their perivascular niche and are thus assumed to support wound healing and tissue regeneration. In vitro MSC exhibit demonstrated capabilities to differentiate into a wide variety of tissue cell types. Hence, many MSC-based therapeutic approaches have been performed to address bone, cartilage, or heart regeneration. Furthermore, prominent studies showed efficacy of ex vivo expanded MSC to countervail graft-vs.-host-disease. Therefore, additional fields of application are presently conceived, in which MSC-based therapies potentially unfold beneficial effects, such as amelioration of non-healing conditions after tendon or spinal cord injury, as well as neuropathies. Working along these lines, MSC-based scientific research has been forged ahead to prominently occupy the clinical stage. Aging is to a great deal stochastic by nature bringing forth changes in an individual fashion. Yet, is aging of stem cells or/and their corresponding niche considered a determining factor for outcome and success of clinical therapies?
Insights
Multipotential mesenchymal stromal cells (MSC) support tissue repair and are used in therapies for conditions like graft-vs.-host disease. However, the impact of aging on MSC function and therapeutic success remains a key question.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Tissue engineering
Background:
- Multipotential mesenchymal stromal cells (MSC) are a rare stromal subpopulation, often found perivascularly, crucial for blood vessel integrity.
- Activated MSC/pericytes migrate from their niche during injury to support wound healing and tissue regeneration.
- In vitro, MSC demonstrate differentiation potential into various cell types, driving therapeutic applications.
Purpose of the Study:
- To explore the therapeutic potential of MSC in regenerative medicine and various clinical conditions.
- To investigate the role of MSC in tissue repair, graft-vs.-host disease, and potential applications in injuries and neuropathies.
- To address the critical question of whether stem cell aging impacts the success of MSC-based clinical therapies.
Main Methods:
- Review of existing literature on MSC biology, therapeutic applications, and aging.
- Analysis of MSC differentiation capabilities in vitro.
- Examination of clinical studies involving ex vivo expanded MSC.
Main Results:
- MSC show promise in bone, cartilage, and heart regeneration, and in mitigating graft-vs.-host disease.
- Potential applications for MSC therapies include non-healing injuries (tendon, spinal cord) and neuropathies.
- MSC research is advancing rapidly, with significant clinical translation efforts.
Conclusions:
- MSC hold considerable therapeutic promise across diverse medical fields.
- The aging process of MSC and their niche is a critical, yet underexplored, factor influencing therapeutic outcomes.
- Further research is needed to understand and mitigate the effects of aging on MSC efficacy in clinical settings.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Mesenchymal Stem Cells
Adult Stem Cells
iPS Cell Differentiation

